+351 211 369 829 
DNA methylation fingerprint of hepatocellular carcinoma …
As part of our Liquid Biopsy development pipeline, we are identifying biomarkers and developing algorithms that can change the way liver cancer is det
HepatoPredict (medical device) registration
Another important step in the development of HepatoPredict and an occasion for celebration: HepatoPredict is now a registered medical device under the
HepatoPredict presented at the ESA Meeting
Our collaborator from the Cento Hospital Universitário de Lisboa Central (Hospital Curry Cabral) presented an oral communication and discussed our wo
Ophiomics presenting HepatoPredict at the ILTS Annual meeting
If you are attending the annual meeting of the International Liver Transplantation Society, come hear about HepatoPredict on Saturday morning, Room 1
Prof. M. Berenguer Joins Ophiomics’ Advisory Board
It is with great joy that we announce that Prof. Marina Berenguer joined Ophiomics’ advisory board. (From ILTS site) Prof. Marina Berenguer is a C
Ophiomics and Biocartis to Collaborate on Liver Cancer Test
Ophiomics (PT) and Biocartis (BE) announce today that they have entered into a collaboration regarding HepatoPredict™, a prognostic test for liver c
Ophiomics exhibiting at Arab Health 2022
🚀Off to #ArabHealth2022🇦🇪 with the #EUeic Overseas Trade Fairs ✈Programme 2.0!Do not miss the chance to visit us at the European Pavilion &
Ophiomics starts manufacturing HepatoPredict.
On the last days of 2021 Ophiomics launched the fabrication of its first “production-scale” lot of the HepatoPredict kit, already in prepara
Ophiomics presenting at the European Society for Surgical Oncology Meeting
Jose Leal presented HepatoPredict at the ESSO 40, in the session Future Oncology, where he had the opportunity to discuss HepatoPredict and its valida
Prof. C Duvoux joins Ophiomics’ Advisory Board.
It is with great joy that we announce that Prof. Christophe Duvoux joined Ophiomics’ advisory board. (From the ILTS site:) Christophe Duvoux i
Ophiomics participates in the International Liver Congress 2021
Our team is participating in one of the largest congresses about liver diseases with the aim of joining the global liver community to connect and
Ophiomics secures €1M in Seed Round as part of an EIC accelerator award.
Ophiomics secures €1M in Seed Round as part of an EIC accelerator award. Funding round will support regulatory compliance and clinical validation Li